PEDMARQSI is the First and Only Approved Therapy in the EU and U.K. for the Prevention of Ototoxicity, or Hearing Loss, Induced by Cisplatin ...

SickKids researchers identified the KCNB2 gene as a key driver of medulloblastoma tumor growth. Blocking KCNB2 disrupts potassium channels, causing tumor-propagating cells to swell and lose integrity.

The liver is a common site for metastasis because it filters and receives blood from other parts of the body. Metastasis may also be simply referred to as cancer spread. If you have lung cancer that ...

These may be the words my oncologist used when he told me that I was now metastatic, but, to be honest, I can’t recall them clearly. What I can remember are the emotions: shock, disbelief ...

“Our study demonstrates the critical role of PSMA-PET in accurately staging prostate cancer, which can significantly impact treatment decisions and outcomes,” said Jeremie Calais, MD, PhD.

Primary cancer is defined as the original site (organ or tissue) where cancer began. In contrast, a second or secondary cancer may be defined in a few ways; as either a new primary cancer in another ...

A study published in Nature Genetics reveals new insights into how medulloblastoma, the most common malignant brain tumor of childhood, can arise as the cerebellum develops. Researchers discovered ...

Medulloblastoma is the most common brain malignancy in children and tremendous advances have recently been made in understanding the pathogenesis of this tumor. The Hedgehog and Wingless signaling ...

Nivolumab is under clinical development by Bristol-Myers Squibb and currently in Phase II for Neuroendocrine Tumors. According to GlobalData, Phase II drugs for Neuroendocrine Tumors have a 28% phase ...

Nivolumab is under clinical development by Bristol-Myers Squibb and currently in Phase II for Osteosarcoma. According to GlobalData, Phase II drugs for Osteosarcoma have a 13% phase transition success ...